Latest Administration News

Optiscan Imaging Ltd has launched a fully underwritten $17.75 million entitlement offer to fund clinical trials and regulatory clearances for its medical devices, marking a pivotal step in its transition to a commercial medical device manufacturer.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Talius Group Limited reported a 21% increase in sales revenue for the first half of 2025, driven by strong hardware sales and recurring software subscriptions. The company also completed a major contract rollout and achieved significant cost reductions, positioning itself for growth amid evolving aged care sector dynamics.

ADX Energy has updated its Upper Austria prospect inventory, reporting a substantial net mean prospective resource of 374 million barrels of oil equivalent and outlining near-term drilling plans focused on low-risk shallow gas and near-field oil plays.

One Click Group Limited reported a 27.6% revenue increase to $1.33 million in H1 2025, driven by its expanding fintech platform, One Click Life. Despite this growth, the company remains loss-making as it invests in scaling its user base and product offerings.

Domino’s Pizza Enterprises announces a 21.5 cents per share final dividend for FY25, alongside a Dividend Reinvestment Plan offering shares at a 1% discount over a 10-day pricing period starting September 8.

Wisr Limited’s FY2025 results reveal a modest revenue decline alongside increased losses, with no dividends declared, highlighting ongoing challenges for the fintech lender.

EBOS Group Limited reported a steady FY25 with 12% revenue growth and EBITDA in line with guidance, driven by strong healthcare and animal care segments. The company signals confidence with maintained dividends and a positive FY26 outlook.

Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.

Ironbark Capital Limited reported a 17.6% increase in net profit for FY2025, driven by higher investment income and realised gains, alongside a raised fully franked dividend and an extended share buy-back program.

Australis Oil & Gas reported a reduced half-year loss and positive cash flow despite lower production, while actively seeking a development partner for its Tuscaloosa Marine Shale assets.